Dagmar is a well-rounded professional with 20 years of experience who thrives on leading global scale transformations and loves to engage with others to achieve extraordinary outcomes together. Her working style is characterized by high energy and high impact. Dagmar continues to build strong expertise in outcome measurement and patient data management (eg compliance, data privacy, blockchain technology, registries). She is interested in leveraging innovation and digital technology to advance healthcare and accelerate research.
Dagmar's educational background is in law (Ph.D.) and she is experienced in working in multicultural settings worldwide.
She spent 16 years working in a multinational environment as a global HR Manager in various roles at Shell (RDS). She is experienced in bringing a company's EVP (Employee Value Proposition) to life by engaging the hearts & minds of employees and unleashing their full commitment.
She is the mother of 3 children, one of which has the rare genetic bone disease Osteogenesis Imperfecta (OI). This led her to found and chair the Foundation Care4BrittleBones since 2012. This organization is recognized as a game changer in the area of rare bone diseases. She is experienced in coordinating and delivering research projects co-created with patient organizations and all other relevant stakeholders.
Dagmar is accredited and experienced in various leadership interventions and coaching methodologies, which are powerful tools to unleash the power of patient organizations as well as tapping into the full potential of leaders and employees in a pharmaceutical company.
She acts as an advisor to patient organizations to develop more impact (Strategy / Vision setting, Operational planning, organizational and volunteer management, evaluation and impact measurement, databases & registries, development of a Core Outcome Set, professionalizing volunteer organizations, support tools such as animated videos, crowdfunding, patient surveys, storytelling for change, podcasts, infographics, etc). From this, she developed and maintains strong networks to research institutions, healthcare providers and patient organizations, especially in the rare bone sector.